Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

Assessment of Selective Homing and Contribution to Vessel Formation of Cryopreserved Peripherally Injected Bone Marrow Mononuclear Cells Following Experimental Myocardial Damage

Volume:6   Issue: 3
Pp: 141-149
M. M. Ciulla, S. Ferrero, E. Montelatici, U. Gianelli, P. Braidotti, S. Calderoni, R. Paliotti, G. Annoni, E. De Camilli, G. Busca, F. Magrin, S. Bosari, L. Lazzari and P. Rebulla
DOI: 10.2174/187152906778249563

Nutritional Control, Gene Regulation, and Transformation of Vascular Smooth Muscle Cells in Atherosclerosis

Volume:6   Issue: 3
Pp: 151-168
A. Linares, S. Perales, R. J. Palomino-Morales, M. Castillo and M. J. Alejandre
DOI: 10.2174/187152906778249545

Physiological and Pharmacological Insights into the Role of Ionic Channels in Cardiac Pacemaker Activity

Volume:6   Issue: 3
Pp: 169-190
B. Couette, L. Marger, J. Nargeot and M. E. Mangoni
DOI: 10.2174/187152906778249572

Development of Monoclonal Antibodies that Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs

Volume:6   Issue: 3
Pp: 191-207
S. F. De Meyer, K. Vanhoorelbeke, H. Ulrichts, S. Staelens, H. B. Feys, I. Salles, A. Fontayne and H. Deckmyn
DOI: 10.2174/187152906778249536

Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis

Volume:6   Issue: 3
Pp: 209-217
S. Nachimuthu and P. Raggi
DOI: 10.2174/187152906778249554